Swiss biotech Actelion hits record high on potential Shire bid

LONDON (Reuters) - Shares in Actelion , Europe's biggest biotech company, jumped 10 percent to a record high on Monday after a report Shirewas considering a $19 billion takeover of the Swiss group...